These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25978606)

  • 1. Klotho protein: A potential therapeutic agent during myocardial ischemia and reperfusion.
    Zhou X; Li Sy; Wang Z; Yu L; Jiang H
    Int J Cardiol; 2015 Jul; 191():227-8. PubMed ID: 25978606
    [No Abstract]   [Full Text] [Related]  

  • 2. Modifying the first minute of reperfusion: potential for myocardial salvage.
    Diaz RJ; Wilson GJ
    Cardiovasc Res; 2004 Apr; 62(1):4-6. PubMed ID: 15023547
    [No Abstract]   [Full Text] [Related]  

  • 3. [Amiloride decreases heart susceptibility to "calcium paradox" after total ischemia].
    Alabovskiĭ VV; Vinokurov AA
    Fiziol Zh (1994); 1994; 40(2):92-6. PubMed ID: 7758612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of the ischemic heart during reperfusion: role of the low flow to avoid calcium overload into the myocardium in a pig model.
    Ferrera R; Michel P
    Transplant Proc; 2002 Dec; 34(8):3265-7. PubMed ID: 12493442
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of the myocardial protective effect of rapid cooling based on intracellular Ca, intracellular pH, and HSP70.
    Inoue K; Ando S; Gyuan F; Takaba T
    Ann Thorac Cardiovasc Surg; 2003 Oct; 9(5):301-6. PubMed ID: 14672526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating endoplasmic reticulum stress to alleviate myocardial ischemia and reperfusion injury from basic research to clinical practice: A long way to go.
    Wu H; Ye M; Yang J; Ding J
    Int J Cardiol; 2016 Nov; 223():630-631. PubMed ID: 27565840
    [No Abstract]   [Full Text] [Related]  

  • 7. HDAC inhibition: A novel therapeutic target for attenuating myocardial ischemia and reperfusion injury by reversing cardiac remodeling.
    Wang J; Hu X; Jiang H
    Int J Cardiol; 2015; 190():126-7. PubMed ID: 25918063
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of aprotinin on gene expression and protein synthesis after ischemia and reperfusion in rats.
    Buerke M; Pruefer D; Sankat D; Carter JM; Buerke U; Russ M; Schlitt A; Friedrich I; Börgermann J; Vahl CF; Werdan K
    Circulation; 2007 Sep; 116(11 Suppl):I121-6. PubMed ID: 17846291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giving the ischaemic heart a shot in the arm.
    Ovize M; Bonnefoy E
    Lancet; 2010 Feb; 375(9716):699-700. PubMed ID: 20189010
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myocardial reperfusion: salvation or danger for the heart muscle? Stunning, hibernation and preconditioning: the states of endogenous cardiac protection against ischemia].
    Atar D
    Schweiz Med Wochenschr; 1997 Nov; 127(48):2008-13. PubMed ID: 9490468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion.
    Kin H; Zhao ZQ; Sun HY; Wang NP; Corvera JS; Halkos ME; Kerendi F; Guyton RA; Vinten-Johansen J
    Cardiovasc Res; 2004 Apr; 62(1):74-85. PubMed ID: 15023554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-α inhibitor: A promising therapeutic approach for attenuating myocardial ischemia-reperfusion by antioxidant stress.
    Zhou X; Sheng X; Chen M; Wang Z; Yu L; Jiang H
    Int J Cardiol; 2015; 190():282-3. PubMed ID: 25932807
    [No Abstract]   [Full Text] [Related]  

  • 13. Opioids and myocardial reperfusion injury.
    Gross GJ; Peart JN
    Arch Mal Coeur Vaiss; 2007 Mar; 100(3):231-7. PubMed ID: 17536429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial protection for coronary artery bypass in patients with acute myocardial infarction: resuscitation of ischemic myocardium.
    Brown WM; Horsley WS; Gott JP; Bufkin BL; Guyton RA
    Semin Thorac Cardiovasc Surg; 1995 Oct; 7(4):191-7. PubMed ID: 8590743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of L-arginine enriched cardioplegia and non-cardioplegic reperfusion in ischemic hearts.
    Kiziltepe U; Tunçtan B; Eyileten ZB; Sirlak M; Arikbuku M; Tasoz R; Uysalel A; Ozyurda U
    Int J Cardiol; 2004 Oct; 97(1):93-100. PubMed ID: 15336814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic preconditioning of JTE-607, a novel cytokine inhibitor, attenuates ischemia-reperfusion injury in the myocardium.
    Ryugo M; Sawa Y; Ono M; Miyamoto Y; Aleshin AN; Matsuda H
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1723-7. PubMed ID: 15173729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvasculature sparing with controlled reperfusion of ischemic myocardium.
    Mrak RE; Murphy ML; Peng CF; Straub KD
    Am J Cardiovasc Pathol; 1990; 3(3):253-8. PubMed ID: 2095831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stunning, preconditioning and hibernation; aspects of ischemia and reperfusion of the myocardium].
    Ruigrok TJ
    Ned Tijdschr Geneeskd; 1993 Dec; 137(49):2526-32. PubMed ID: 8272138
    [No Abstract]   [Full Text] [Related]  

  • 19. Stunned and hibernating myocardium: possibility of intervention.
    Ferrari R; La Canna G; Giubbini R; Visioli O
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S5-13. PubMed ID: 1282614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial protection from ischemia-reperfusion injury post coronary revascularization.
    Binder A; Ali A; Chawla R; Aziz HA; Abbate A; Jovin IS
    Expert Rev Cardiovasc Ther; 2015; 13(9):1045-57. PubMed ID: 26202544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.